Sun Pharma is Great Place To Work® Certified™ in 25 countries
Sun Pharmaceutical Industries Ltd.
by
3M ago
We are proud to have earned the Great Place To Work Certification™ in 25 countries across the globe. The certification was earned by Sun Pharma based on the Trust Index™ Survey by the Great Place To Work (GPTW) Institute. Over 38,000 employees participated in the global survey ..read more
Visit website
Celebrating 40 Years in Malaysia
Sun Pharmaceutical Industries Ltd.
by
5M ago
This year marks a significant milestone for our team in Malaysia as they celebrate 40 years of successful operations in the country ..read more
Visit website
Sun Pharma Recognized as a Great Place to Work in India
Sun Pharmaceutical Industries Ltd.
by
5M ago
In the world of pharmaceutical manufacturing, a domain predominantly associated with men in hard hats and assembly lines, a remarkable transformation has been taking place at Sun’s Dewas plant in India. It’s a tale of breaking the mould and creating a gender diverse team to manage manufacturing blocks ..read more
Visit website
Sun Pharma No. 1 Generic Company in PatientView Survey
Sun Pharmaceutical Industries Ltd.
by
5M ago
At Sun, our patients are at the centre of everything we do. We are committed to helping them lead happier and healthier lives. When we see the difference our work makes in people’s lives, it inspires us to do better ..read more
Visit website
Sun Pharma’s Dewas Plant Champions Diversity in Manufacturing
Sun Pharmaceutical Industries Ltd.
by
5M ago
In the world of pharmaceutical manufacturing, a domain predominantly associated with men in hard hats and assembly lines, a remarkable transformation has been taking place at Sun’s Dewas plant in India. It’s a tale of breaking the mould and creating a gender diverse team to manage manufacturing blocks ..read more
Visit website
Q2 FY24 Financial Press Release
Sun Pharmaceutical Industries Ltd.
by
6M ago
..read more
Visit website
Sun Pharma and Zydus sign licensing agreement for co-marketing of Desidustat in India
Sun Pharmaceutical Industries Ltd.
by
7M ago
Sun Pharma and Zydus sign licensing agreement for co-marketing of Desidustat in India ..read more
Visit website
CEQUA® (cyclosporine ophthalmic solution) 0.09% Phase 4 Data Showed Sustained Improvement in Dry Eye Disease Signs and Symptoms in Patients Switched From Restasis® (cyclosporine ophthalmic emulsion) 0.05%
Sun Pharmaceutical Industries Ltd.
by
7M ago
CEQUA® (cyclosporine ophthalmic solution) 0.09% Phase 4 Data Showed Sustained Improvement in Dry Eye Disease Signs and Symptoms in Patients Switched From Restasis® (cyclosporine ophthalmic emulsion) 0.05 ..read more
Visit website
Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma
Sun Pharmaceutical Industries Ltd.
by
7M ago
Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma ..read more
Visit website
Sun Pharma to announce second quarter results on November 01, 2023
Sun Pharmaceutical Industries Ltd.
by
7M ago
Sun Pharma to announce second quarter results on November 01, 2023 ..read more
Visit website

Follow Sun Pharmaceutical Industries Ltd. on FeedSpot

Continue with Google
Continue with Apple
OR